Article
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population.
PloS one - 1 Jan 2015
Rosini Roberto, Campisi Edmondo, De Chiara Matteo, Tettelin Hervé, Rinaudo Daniela, Toniolo Chiara, Metruccio Matteo, Guidotti Silvia, Sørensen Uffe B Skov, Kilian Mogens, Ramirez Mario, Janulczyk Robert, Donati Claudio, Grandi Guido, Margarit Immaculada
Abstract excerpt
The human and bovine bacterial pathogen Streptococcus agalactiae (Group B Streptococcus, GBS) expresses a thick polysaccharide capsule that constitutes a major virulence factor and vaccine target. GBS can be classified into ten distinct serotypes differing in the chemical composition of their cap...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
